Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Dalacin T Topical Lotion 10mg/ml Cutaneous Emulsion - PA0822/121/001
- Epivir 10mg/ml Oral Solution - EU/1/96/015/002
- Exelon 9.5mg/24 hours Transdermal Patch - EU/1/98/066/040
- Lantus 100 units/ml Solution for Injection in a Vial - EU/1/00/134/012
- Ondansetron 2mg/ml Solution for Injection - PA1122/004/001
- Pregabalin Sandoz 100mg Hard Capsules - EU/1/15/1011
- Quetex XR 50mg Prolonged Release Tablets - PA0711/258/001
- Rowalief 500mg Film Coated Tablets (300 pack) - PA0074/065/001
- Triapin 5mg/5mg Prolonged Release Tablets - PA0540/082/002
The following shortages have been resolved and supply has resumed to the Irish market:
- Arava 10mg Film Coated Tablets - EU/1/99/118/003
- DuoPlavin 75mg/75mg Film Coated Tablets - EU/1/10/619/002
- Dynastat 40mg Powder for Solution for Injection - EU/1/02/209/005
- Eumovate Cream 0.05% - PA1077/006/001
- Instanyl 50mcg Nasal Spray - EU/1/09/531/010-013
- Irinotecan Hydrochloride 20mg/ml Concentrate for Solution for Infusion (100mg/5ml) - PA1986/068/001
- Provera 10mg Tablets - PA0822/134/003
- Roactemra 162mg Solution for Injection in Pre Filled Pen - EU/1/08/492/009
- Sandimmun 100 mg/ml Concentrate for Oral Solution - PA0896/027/001
- Somavert 15mg Powder and Solvent for Solution for Injection - EU/1/02/240/002
- Spironolactone 25mg Film Coated Tablets - PA2315/119/001
- Sublimaze 50mcg/ml, Solution for Injection - PA22583/002/001
- Targocid 200mg Powder and Solvent for Solution for Injection/Infusion or Oral Solution - PA0540/021/001
- Targocid 400mg Powder and Solvent for Solution for Injection/Infusion or Oral Solution - PA0540/021/002
- Toviaz 4mg Prolonged Release Tablets - EU/1/07/386/003
- Toviaz 8mg Prolonged Release Tablets - EU/1/07/386/008
- Voriconazole 200mg Powder for Solution for Infusion - PA2059/020/001
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.